台股 » 個股 » 逸達 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

逸達

(6576)
  • 股價
    77.5
  • 漲跌
    ▲0.5
  • 漲幅
    +0.65%
  • 成交量
    191
  • 產業
    上櫃 生技醫療類股
  • 118人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
逸達 (6576)籌碼相關-臺銀-高雄 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

臺銀-高雄 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/1300.00176.1076.10-1194-0.51%
2025/01/0900.00076.5076.8001920.00%
2025/01/0700.00177.4077.70-1191-0.52%
2024/12/2600.00177.0077.80-1183-0.55%
2024/12/2000.00176.0075.90-1170-0.59%
2024/12/1800.00174.7075.90-1171-0.58%
2024/12/1600.00473.0072.90-4164-2.42%
2024/12/11174.0000.0073.8011580.63%
2024/12/10075.00874.3473.40-8156-5.10%
2024/12/09275.4500.0075.4021491.34%
2024/12/03277.1000.0078.3021411.42%
2024/12/02376.87177.0078.5021371.46%
2024/11/29277.60277.6077.0001330.00%
2024/11/25079.7000.0080.3001280.00%
2024/11/2000.00079.5076.8001010.00%
2024/11/08179.2000.0079.3011070.93%
2024/11/04177.1000.0076.6011100.91%
2024/10/2300.00077.4077.9001360.00%
2024/10/22176.9000.0076.8011370.73%
2024/10/2100.00077.8077.8001390.00%
2024/09/2700.00182.6082.40-1183-0.54%
2024/09/20181.7000.0081.7012070.48%
2024/09/09179.6000.0079.6012610.38%
2024/09/0500.00078.5078.8002650.00%
2024/09/0300.00080.2080.4002840.00%
2024/08/2900.00082.3082.0002950.00%
2024/08/2800.00182.5082.30-1296-0.34%
2024/08/2100.00078.4079.7002940.00%
2024/08/1500.00377.7078.00-3294-1.02%
2024/08/07176.4000.0076.6013020.33%
2024/08/06169.4000.0072.0013010.33%
2024/08/05172.0000.0072.5012990.33%
2024/08/0200.00081.5079.5002910.00%
2024/07/31280.2000.0080.0022960.68%
2024/07/19182.4000.0082.6012830.35%
2024/07/18183.00283.1583.20-1280-0.36%
2024/07/17184.7000.0083.8012790.36%
2024/07/12183.0000.0083.4012820.35%
2024/07/101.583.971283.2083.30-10.5283-3.71%
2024/07/0900.00583.7083.60-5280-1.78%
2024/07/05185.5000.0084.7012780.36%
2024/06/250.483.60181.1083.50-0.6260-0.23%
2024/06/24292.2500.0089.2022380.84%
2024/06/14196.6000.0097.1012170.46%
2024/06/070.399.5000.0099.600.32200.14%
2024/06/0500.00096.5097.0002060.00%
2024/05/200.394.5000.0094.700.32700.11%
2024/05/15193.5000.0093.6013210.31%
2024/05/03195.8000.0095.7013130.32%
2024/04/2400.00094.0095.1003210.00%
2024/04/22094.6500.0094.0003310.00%
2024/04/19094.0000.0093.6003390.00%
2024/04/18097.0700.0097.0003290.00%
2024/04/16296.4500.0096.8023340.60%
2024/04/15198.90198.6098.3003310.00%
2024/04/1100.002199.0799.40-21331-6.34%
2024/04/1000.003999.3399.40-39330-11.79%
2024/04/0900.00198.7099.10-1332-0.30%
2024/04/082101.0000.0099.6023290.61%
2024/04/01297.9000.0098.0023330.60%
2024/03/21194.6000.0095.0013780.26%
2024/03/1300.00695.2095.70-6370-1.62%
2024/03/12096.0000.0096.1003690.00%
2024/03/08195.001095.5095.70-9372-2.42%
2024/03/07199.6000.0099.0013620.28%
2024/03/06199.9000.00100.0013550.28%
2024/03/0400.001102.00102.00-1349-0.29%
2024/02/2700.002103.00103.50-2342-0.58%
2024/02/221102.501101.50102.0003520.00%
2024/02/201105.5000.00106.0013400.29%
2024/02/1600.00197.1097.80-1288-0.35%
2024/02/05294.8000.0094.4022820.71%
逸達前列腺癌新劑型新藥 確立美國藥證審查完成目標日Anue鉅亨-19天前
逸達營收/去年4.2億、年增115% 今年拚歐、美、中新藥藥證UDN聯合新聞網-25天前
逸達進軍歐盟 首批前列腺癌新劑型新藥正式出貨Anue鉅亨-2024/12/18
逸達 相關文章
逸達 相關影音